October 30,2007
Grassley delves further into FDA review of foreign-made pharmaceuticals
WASHINGTON — Sen. Chuck Grassley is following up on his initial inquiry of the Food and Drug Administration regarding its work to ensure the safety of foreign-made pharmaceutical ingredients and medicines with a series of questions about foreign inspection funding, FDA registration of foreign plants, newly emerging exporters of pharmaceuticals, and weaknesses in the foreign inspection process.
The text of the letter he sent today to the FDA Commissioner follows here, along with the text of his August letter.
###
Next Article Previous Article
Recent News
- Wyden Praises Trade Court Decision Striking Down Trump’s Illegal Global Tariffs
- Wyden Statement on House Passage of Reconciliation Legislation
- Wyden Warns Republicans that Overruling Parliamentarian to Nix California Clean Air Waiver Will Backfire
- Wyden Statement on IRS Nominee Billy Long's Involvement in Tax Scams
- Wyden Opposes HHS Nominees O'Neill and Andres to be Deputy Secretary and Congressional Liaison